Latest Breaking News On - Analgesic program - Page 5 : comparemela.com

PreveCeutical Medical Inc : PreveCeutical Files Provisional Patent Application for D-Amino Acid Peptides

Vancouver, British Columbia (Newsfile Corp. - November 24, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce it has filed

United kingdomUnited statesBritish columbiaStephen van deventerPreveceutical medical incCompany or preveceuticalAustralian patent office onBritish columbia newsfile corpCanadian securities exchangeCeutical medicalAustralian patent officeChief executive officerVan deventerChief executiveLooking statementsAnalgesic program

PreveCeutical Medical Inc : PreveCeutical Files International Patent Application for its Dynorphin Peptides

PreveCeutical Medical Inc : PreveCeutical Files International Patent Application for its Dynorphin Peptides
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBritish columbiaStephen van deventerPreveceutical medical incCompany or preveceuticalBritish columbia newsfile corpCanadian securities exchangeCeutical medicalChief executive officerVan deventerChief executiveLooking statementsAnalgesic programஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்

PreveCeutical Files International Patent Application for its | The Kingston Whig Standard

PreveCeutical Files International Patent Application for its | The Kingston Whig Standard
thewhig.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thewhig.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBritish columbiaStephen van deventerPreveceutical files international patent applicationPreveceutical medical incNewsfile corpCompany or preveceuticalCanadian securities exchangeDynorphin peptidesPreveceutical medicalChief executive officerVan deventerChief executiveLooking statementsAnalgesic program